CVTX

CV Therapeutics (CVTX)

CV Therapeutics (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CVTX

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Date	Time	Source	Headline	Symbol	Company
08/14/2008	4:01PM	PR Newswire (US)	CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)	NASDAQ:CVTX	CV Therapeutics (MM)
08/14/2008	1:15PM	PR Newswire (US)	CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award	NASDAQ:CVTX	CV Therapeutics (MM)
08/13/2008	1:58PM	Edgar (US Regulatory)	CV Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
08/01/2008	2:18PM	Edgar (US Regulatory)	CV Therapeutics Inc - Quarterly Report (10-Q)	NASDAQ:CVTX	CV Therapeutics (MM)
08/01/2008	1:27PM	Edgar (US Regulatory)	CV Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
07/31/2008	4:07PM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
07/31/2008	4:01PM	PR Newswire (US)	CV Therapeutics Reports 2008 Second Quarter Financial Results	NASDAQ:CVTX	CV Therapeutics (MM)
07/28/2008	2:19PM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
07/28/2008	7:00AM	PR Newswire (US)	CVT Announces That FDA Continues to Review Ranexa(R) Applications	NASDAQ:CVTX	CV Therapeutics (MM)
07/22/2008	4:01PM	PR Newswire (US)	CV Therapeutics to Announce 2008 Second Quarter Financial Results on Thursday, July 31, 2008	NASDAQ:CVTX	CV Therapeutics (MM)
07/10/2008	4:01PM	PR Newswire (US)	CV Therapeutics Receives European Marketing Authorization for Ranolazine for the Treatment of Patients With Chronic Angina	NASDAQ:CVTX	CV Therapeutics (MM)
07/09/2008	3:40PM	Edgar (US Regulatory)	CV Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
06/24/2008	1:06PM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
06/24/2008	9:40AM	PR Newswire (US)	Commercial Launch of Lexiscan(TM) (Regadenoson) Injection Triggers $10 Million Milestone Payment from TPG-Axon Capital to CV The	NASDAQ:CVTX	CV Therapeutics (MM)
06/24/2008	9:38AM	PR Newswire (US)	Astellas Launches Lexiscan(TM) (Regadenoson) Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfus	NASDAQ:CVTX	CV Therapeutics (MM)
06/24/2008	6:01AM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
06/23/2008	4:01PM	PR Newswire (US)	CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Prem	NASDAQ:CVTX	CV Therapeutics (MM)
06/18/2008	5:30PM	Edgar (US Regulatory)	CV Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
06/12/2008	3:12PM	Edgar (US Regulatory)	CV Therapeutics Inc - Statement of Ownership (SC 13G)	NASDAQ:CVTX	CV Therapeutics (MM)
06/09/2008	4:26PM	Edgar (US Regulatory)	CV Therapeutics Inc - Statement of Ownership (SC 13G)	NASDAQ:CVTX	CV Therapeutics (MM)
05/30/2008	2:28PM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
05/28/2008	5:01PM	PR Newswire (US)	CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350	NASDAQ:CVTX	CV Therapeutics (MM)
05/27/2008	5:01PM	PR Newswire (US)	CV Therapeutics Announces Presentations at the American Diabetes Association 68th Scientific Sessions	NASDAQ:CVTX	CV Therapeutics (MM)
05/21/2008	4:09PM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
05/08/2008	1:47PM	Edgar (US Regulatory)	CV Therapeutics Inc - Quarterly Report (10-Q)	NASDAQ:CVTX	CV Therapeutics (MM)
05/01/2008	4:35PM	Edgar (US Regulatory)	CV Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
04/29/2008	4:04PM	Edgar (US Regulatory)	CV Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
04/28/2008	5:24PM	Edgar (US Regulatory)	CV Therapeutics Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CVTX	CV Therapeutics (MM)
04/28/2008	1:55PM	Edgar (US Regulatory)	CV Therapeutics Inc - Proxy Statement (definitive) (DEF 14A)	NASDAQ:CVTX	CV Therapeutics (MM)
04/28/2008	1:00PM	Edgar (US Regulatory)	CV Therapeutics Inc - Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)